Amarin | AMRN - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
AbbVie USD 6.57B 2.82B 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amarin USD 143.56M 12.5M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
DBV Technologies USD 174.9M 54.3M 2026-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06